Nasomet (Mometasone) is a corticosteroid demonstrating anti-inflammatory properties. The precise mechanism of corticosteroid's action on allergic rhinitis is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation.
Oxymetazoline Hydrochloride, the active ingredient of Nazolin® nasal spray, is a sympathomimetic amine of the imidazoline class. Nazolin® is indicated for the following purposes as a nasal decongestant in allergic rhinitis, with or without the addition of topical antihistamines or sodium cromoglycate; as a nasal decongestant in sinusitis where there is evidence of obstruction of ostea to the sinuses; as nasal decongestant in otitis media where there is evidence of obstruction of eustachian tube, especially in subacute serous otitis media (glue ear) and otitic barotrauma; as a decongestant in an infective rhinitis(e.g. an acute viral upper respiratory tract infection). where there is a secondary bacterial infection, there is no evidence of benefit.
Perinase® nasal spray is an aqueous suspension of microfine Fluticasone Propionate for topical administration to the nasal mucosa by means of a metering, atomizing spray pump. The active ingredient Fluticasone Propionate is a synthetic corticosteroid.Perinase® nasal spray is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults and pediatric patients 4 years of age and older.